<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="2e4eacdf-4d66-458e-837d-1c53cb5e64ba"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Muhammad Ali</title>
  <effectiveTime value="20260609120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="4008f030-7709-4b40-bc1e-499a8ce85020"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="ea31eb2c-ff4a-429a-ae1d-90f686311a15" extension="HR-BX001-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-01-7724"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Muhammad</given><family>Ali</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19720117"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260609120000-0500"/>
    <assignedAuthor><id root="bcd49d73-7241-4981-81b8-41e8ba245352"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Moreau</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260609120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="bcd49d73-7241-4981-81b8-41e8ba245352"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Moreau</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260609"/><high value="20260609"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="bcd49d73-7241-4981-81b8-41e8ba245352"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Moreau</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="28728b2c-3e7b-48b3-9139-0da1a7b67346"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Three-month Parkinson&apos;s disease review after the levodopa increase and speech therapy</originalText></code>
      <effectiveTime><low value="20260609"/><high value="20260609"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="bcd49d73-7241-4981-81b8-41e8ba245352"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Moreau</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Three-month Parkinson&apos;s disease review after the levodopa increase and speech therapy. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Ali returns three months after his first visit. Since carbidopa-levodopa was increased to one and a half tablets three times a day, taken 30 minutes before meals, he is quicker with buttons and getting out of chairs, and the late-morning slowness has eased. He has had no involuntary movements, no wearing-off before doses, and no lightheadedness on standing, nausea, or sleepiness. He finished the four-week LSVT LOUD speech therapy course two months ago and practices his voice exercises each day; people hear him more easily. He has had six physical therapy sessions and now walks, rides a stationary bicycle, and does balance exercises about 150 minutes a week. He has had no falls. He has had no hallucinations. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Medicine change</td><td>Levodopa 150 mg three times daily before meals for twelve weeks; slowness better</td></tr><tr><td>Motor complications</td><td>No dyskinesia or wearing-off</td></tr><tr><td>Rehabilitation</td><td>LSVT LOUD course completed; six physical therapy sessions; home program about 150 minutes a week</td></tr><tr><td>Falls</td><td>None</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Cardiovascular</td><td>Negative</td><td>No lightheadedness on standing or fainting</td></tr><tr><td>Gastrointestinal</td><td>Negative</td><td>No nausea or constipation</td></tr><tr><td>Neurological</td><td>Positive</td><td>Slowness improved; mild right-hand tremor; no involuntary movements or freezing</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; no hallucinations</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times daily</td><td>One tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m.</td><td>Oral route</td><td>2014-10-01 to 2026-03-10</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before meals</td><td>One and a half tablets (levodopa 150 mg) by mouth three times daily, 30 minutes before meals</td><td>Oral route</td><td>2026-03-10</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="6551e448-b0a7-4599-8d39-d5a410df7dd2"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20141001"/><high value="20260310"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197444" codeSystem="2.16.840.1.113883.6.88" displayName="carbidopa 25 MG / levodopa 100 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="838070f0-0a28-4ba9-9eb1-c9ca6cf8e933"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G20.A1" codeSystem="2.16.840.1.113883.6.90" displayName="Parkinson&apos;s disease without dyskinesia, without mention of fluctuations"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="0d59a6ff-bce2-42a7-b8f6-d9ef729b18c5"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260310"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1.5"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197444" codeSystem="2.16.840.1.113883.6.88" displayName="carbidopa 25 MG / levodopa 100 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f9e72853-758a-495a-a90a-da35a7d67edf"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G20.A1" codeSystem="2.16.840.1.113883.6.90" displayName="Parkinson&apos;s disease without dyskinesia, without mention of fluctuations"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e501becf-4aed-46c4-b3ff-6f0a6fab6ca6"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R47.1" codeSystem="2.16.840.1.113883.6.90" displayName="Dysarthria and anarthria"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="a2afb314-3942-4e9f-a0cb-b6b5373288c8"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="3d6a39f0-04a9-49af-9922-80705bc15f16"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>2026-06-09</td><td>Body height</td><td>191</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>2026-06-09</td><td>Body weight</td><td>101.5</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>2026-06-09</td><td>Body mass index (BMI) [Ratio]</td><td>27.8</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>2026-06-09</td><td>Systolic blood pressure</td><td>124</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>2026-06-09</td><td>Diastolic blood pressure</td><td>76</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>2026-06-09</td><td>Heart rate</td><td>72</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>2026-06-09</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>2026-06-09</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>2026-06-09</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="d29b64b5-4580-4585-b20b-0df1fafa06d4"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260609"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a4776589-db40-49d8-8f2d-9b030f5be5e6"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="191" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a3bff25b-4c15-4821-b0c9-6ff4f2a7ba63"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="101.5" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="67bbdd5c-ee7b-4a99-a2e5-4754587e0010"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="27.8" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="42f14587-045f-4706-a366-be9bbdd1211e"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="124" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f182f65c-321d-4e97-92b4-ffaf0530cbde"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="76" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="338278d3-5f9e-4f89-9683-88ec98952410"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="72" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="030aad3f-8f0f-49bd-bca5-6efd74ef73fc"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c25a6542-1fcd-4385-bb25-599356291f9d"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="d67b69a8-7ef8-4952-8fd5-11c95e556dd3"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="20260609"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-06-09; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Alert and engaged; voice noticeably louder in conversation</td></tr><tr><td>Cardiovascular</td><td>Regular rhythm at 72 per minute. Blood pressure 126/78 mmHg supine and 116/76 mmHg after 3 minutes standing, a 10 mmHg fall in systolic pressure, without symptoms; no orthostatic hypotension</td></tr><tr><td>Neurological</td><td>On state: MDS-UPDRS Part III 24, down from 30; Hoehn and Yahr stage 2.5; milder bradykinesia and rigidity; mild right-hand rest tremor; no dyskinesia</td></tr><tr><td>Gait</td><td>Longer steps and better arm swing; recovers after two steps on the pull test; Timed Up and Go 11 seconds</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Parkinson&apos;s disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuations</td><td>active</td><td>confirmed</td>
    <td>G20.A1</td><td>S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic.</td>
  </tr>
  <tr ID="problem-2">
    <td>Hypokinetic dysarthria with soft speech due to Parkinson&apos;s disease</td><td>active</td><td>confirmed</td>
    <td>R47.1</td><td>S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c6d99e81-8460-4669-9dfa-4f3ed2ac5e3e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="7ded4e29-2863-473c-9764-e4db71fec84b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="G20.A1" codeSystem="2.16.840.1.113883.6.90" displayName="Parkinson&apos;s disease without dyskinesia, without mention of fluctuations"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="fdcb3c71-bed1-4091-9178-4f7b7927f6de"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="685a47d9-15ff-4173-bc79-4064e6aef28d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="R47.1" codeSystem="2.16.840.1.113883.6.90" displayName="Dysarthria and anarthria"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Parkinson&apos;s disease, Hoehn and Yahr stage 2.5 (G20.A1)</content>. Good response to the levodopa increase, with MDS-UPDRS Part III down from 30 to 24 and no dyskinesia. The standing blood pressure falls by 10 mmHg, short of the 20 mmHg that defines orthostatic hypotension. Timed Up and Go improved from 13 to 11 seconds with physical therapy. [S]<list><item>Continue carbidopa-levodopa 150 mg three times daily, 30 minutes before meals.</item><item>Continue the home exercise program at 150 minutes a week or more.</item><item>Stand up slowly and drink fluids through the day; report any lightheadedness.</item></list></item><item><content styleCode="Bold">Hypokinetic dysarthria with soft speech (R47.1)</content>. Louder and easier to understand after the speech therapy course. [S]<list><item>Daily voice exercises; refresher course if his voice softens again.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>MDS-UPDRS Parts III and IV and Hoehn and Yahr stage</td><td>Every visit</td><td>Completed today</td><td>Part III 24, down from 30; Hoehn and Yahr 2.5; Part IV: no dyskinesia, wearing-off, or on-off</td></tr><tr><td>Examination</td><td>Orthostatic blood pressure, supine and after 3 minutes standing</td><td>Every visit while on dopaminergic treatment</td><td>Completed today</td><td>126/78 mmHg supine and 116/76 mmHg at 3 minutes standing after the dose increase; no orthostatic hypotension</td></tr><tr><td>Medication safety</td><td>Dopaminergic regimen review for wearing-off, dyskinesia, and on-off</td><td>Every visit</td><td>Completed today</td><td>Good response to levodopa 150 mg three times daily with no motor complications; no change</td></tr><tr><td>Medication safety</td><td>Avoidance of dopamine-blocking drugs</td><td>Every visit</td><td>Completed today</td><td>No dopamine-blocking drugs</td></tr><tr><td>Medication safety</td><td>Medication side effects and adherence</td><td>Every visit</td><td>Completed today</td><td>No nausea, sleepiness, or missed doses; doses now taken before meals</td></tr><tr><td>Examination</td><td>Fall query and fall-risk assessment (Timed Up and Go, pull test)</td><td>Every visit</td><td>Completed today</td><td>No falls; Timed Up and Go 11 seconds, improved from 13; recovers after two steps on the pull test</td></tr><tr><td>Survey</td><td>Psychotic symptoms (hallucinations, delusions)</td><td>Every visit</td><td>Completed today</td><td>None</td></tr><tr><td>Survey</td><td>Impulse-control screen (QUIP-RS)</td><td>Every visit; mandatory on a dopamine agonist</td><td>Deferred</td><td>Not asked at this visit, a deviation from the every-visit item. He is not on a dopamine agonist, and the screen at the six-month review was negative, so no impulse-control problem was missed. Corrective action: the screen is added to the standing visit checklist</td></tr><tr><td>Self-management</td><td>Exercise counseling: aerobic, resistance, and balance, at least 150 minutes a week</td><td>Every visit</td><td>Completed today</td><td>About 150 minutes a week of walking, cycling, and balance exercises</td></tr><tr><td>Self-management</td><td>Advance care planning and goals of care</td><td>At diagnosis and at least yearly</td><td>Due</td><td>Planned for the preventive visit in the autumn</td></tr><tr><td>Examination</td><td>Diagnosis review against the MDS clinical diagnostic criteria</td><td>Yearly</td><td>Up to date</td><td>Confirmed by neurology three months ago</td></tr><tr><td>Survey</td><td>Cognitive screen (MoCA)</td><td>At least yearly</td><td>Up to date</td><td>MoCA 27 of 30 four months ago</td></tr><tr><td>Survey</td><td>Depression, anxiety, and apathy (PHQ-9)</td><td>At least yearly</td><td>Up to date</td><td>PHQ-9 3 four months ago; mood good today</td></tr><tr><td>Survey</td><td>Sleep: REM sleep behavior disorder questionnaire, Epworth Sleepiness Scale, insomnia, restless legs</td><td>At least yearly</td><td>Up to date</td><td>No dream enactment or daytime sleepiness</td></tr><tr><td>Survey</td><td>Autonomic symptoms: constipation, urinary, sexual, sweating, drooling</td><td>At least yearly</td><td>Up to date</td><td>No constipation or urinary symptoms</td></tr><tr><td>Survey</td><td>Swallowing screen (EAT-10)</td><td>At least yearly</td><td>Up to date</td><td>EAT-10 2 four months ago; no choking or coughing with meals since</td></tr><tr><td>Examination</td><td>Speech and voice loudness</td><td>Yearly; speech therapy for speech change</td><td>Completed today</td><td>LSVT LOUD course completed; louder speech today</td></tr><tr><td>Referral</td><td>Physical, occupational, and speech therapy</td><td>At diagnosis, then reassessed yearly</td><td>Completed today</td><td>Speech therapy completed; physical therapy in progress, moving to a home program</td></tr><tr><td>Laboratory</td><td>Genetic testing with counseling</td><td>Once, offered to every person with Parkinson&apos;s disease</td><td>Due</td><td>Offered three months ago; decision at the yearly neurology review</td></tr><tr><td>Examination</td><td>Dental and oral examination</td><td>Every 6 months</td><td>Due</td><td>Not yet arranged; due by six months</td></tr><tr><td>Examination</td><td>Driving safety</td><td>Yearly or with a motor or cognitive change</td><td>Up to date</td><td>Motor function better; review yearly</td></tr><tr><td>Self-management</td><td>Vaccination status (influenza, pneumococcal, zoster, COVID-19, Tdap)</td><td>Yearly, per the CDC schedule</td><td>Due</td><td>To be reviewed at the preventive visit in the autumn</td></tr><tr><td>Laboratory</td><td>Routine laboratory monitoring</td><td>Not required for Parkinson&apos;s disease surveillance</td><td>Not indicated</td><td>The CMID monograph calls for no routine laboratory tests; baseline blood count, chemistry, vitamin B12, and TSH were normal at the first visit</td></tr><tr><td>Imaging</td><td>Brain MRI</td><td>If atypical parkinsonism features appear</td><td>Not indicated</td><td>No atypical features; examination unchanged apart from the improvement</td></tr><tr><td>Imaging</td><td>Polysomnography for REM sleep behavior disorder</td><td>If REM sleep behavior disorder treatment is considered</td><td>Not indicated</td><td>No dream enactment</td></tr><tr><td>Medication safety</td><td>AGS Beers Criteria medication review</td><td>Yearly from age 65</td><td>Not indicated</td><td>He is 54</td></tr><tr><td>Examination</td><td>Deep brain stimulation programming review</td><td>Every 6 to 12 months after implantation</td><td>Not indicated</td><td>No deep brain stimulator</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Less slowness of movement after a levodopa adjustment, without dyskinesia or orthostatic hypotension, by the three-month review. Outcome by 2026-06-09: MDS-UPDRS Part III fell from 30 to 24; no dyskinesia; no orthostatic hypotension [S]</item><item>Complete a four-week intensive speech therapy course and keep up daily voice practice. Outcome by 2026-06-09: LSVT LOUD course completed; easier to hear in conversation; daily home practice continues [S]</item><item>No falls through the six-month review, with at least 150 minutes a week of exercise including balance work. In progress; target 2026-09-08 [S]</item><item>Name a health care agent and record his goals of care by the preventive visit. In progress; target 2026-10-06 [S]</item></list><paragraph>Guideline basis: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee (2021); MDS clinical diagnostic criteria for Parkinson&apos;s disease (2015); The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension (2017); CMID: Clinical Monitoring Intelligence Database, Parkinson&apos;s disease monograph (2026)</paragraph><paragraph>Follow-up: Six-month Parkinson&apos;s disease review in three months. Next scheduled visit 2026-09-08: six-month Parkinson&apos;s disease review. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
